Evaluation of a Thin Strut Metallic Stent: the Elixir DynamX Clinical Study

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 16, 2017

Primary Completion Date

September 17, 2019

Study Completion Date

December 31, 2021

Conditions
Coronary Artery Disease
Interventions
DEVICE

Percutaneous Coronary Intervention

Drug eluting stent implant

Trial Locations (2)

2020

AZ Middelheim Hospital, Antwerp

20132

Ospendale San Raffaele, Milan

Sponsors
All Listed Sponsors
lead

Elixir Medical Corporation

INDUSTRY

NCT03429894 - Evaluation of a Thin Strut Metallic Stent: the Elixir DynamX Clinical Study | Biotech Hunter | Biotech Hunter